Sumatriptan succinate and Glaucoma - a phase IV clinical study of FDA data

Summary:

Glaucoma is reported as a side effect among people who take Sumatriptan succinate (sumatriptan succinate), especially for people who are male, 60+ old, also take Topamax, and have Crohn's disease.

The phase IV clinical study analyzes which people have Glaucoma when taking Sumatriptan succinate. It is created by eHealthMe based on reports of 9,380 people who have side effects when taking Sumatriptan succinate from the FDA, and is updated regularly.

What is Sumatriptan succinate?

Sumatriptan succinate has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 9,731 Sumatriptan succinate users. Check the latest studies of Sumatriptan succinate.

What is Glaucoma?

Glaucoma (increased fluid pressure in the eye with vision loss) is found to be associated with 1,233 drugs and 1,657 conditions by eHealthMe. Check the latest studies of Glaucoma.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

9,380 people reported to have side effects when taking Sumatriptan succinate.
Among them, 17 people (0.18%) have Glaucoma.

Could Sumatriptan succinate cause Glaucoma?

Among these 17 people:

What is the gender of people who have Glaucoma when taking Sumatriptan succinate? *

female: 46.15 %
male: 53.85 %

What is the age of people who have Glaucoma when taking Sumatriptan succinate? *

What are other drugs people take besides Sumatriptan succinate? *

Topamax: 8 people, 47.06%
Azithromycin: 7 people, 41.18%
Flexeril: 7 people, 41.18%
Fluticasone Propionate: 7 people, 41.18%
Ibuprofen: 7 people, 41.18%
Naproxen: 7 people, 41.18%
Nitrofurantoin: 7 people, 41.18%
Amoxicillin: 5 people, 29.41%
Ondansetron: 5 people, 29.41%
Zopiclone: 4 people, 23.53%

What are other side effects people have besides Glaucoma? *

Hyperbilirubinaemia (excess of bilirubin in the blood): 7 people, 41.18%
Craniosynostosis (a baby is born with an abnormally shaped skull or develops one during growth): 7 people, 41.18%
Hearing Loss: 7 people, 41.18%
Developmental Delay: 7 people, 41.18%
Respiratory Disorder (respiratory disease): 7 people, 41.18%
Otitis (ear infection): 6 people, 35.29%
Pneumonia: 6 people, 35.29%
Bronchial Hyperreactivity: 5 people, 29.41%
Somatoform Pain Disorder (a mental disorder characterized by symptoms that suggest pain): 5 people, 29.41%
Dyspnea (difficult or laboured breathing): 5 people, 29.41%

What are the existing conditions these people have? *

Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 4 people, 23.53%
Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 4 people, 23.53%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 23.53%
Sciatic Nerve Injury: 3 people, 17.65%
Torticollis (a twisted neck in which the head is tipped to one side, while the chin is turned to the other): 1 person, 5.88%
Thyroid Diseases: 1 person, 5.88%
Multiple Myeloma (cancer of the plasma cells): 1 person, 5.88%
Indigestion: 1 person, 5.88%
Headache (pain in head): 1 person, 5.88%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Sumatriptan succinate and have Glaucoma?

- Check whether Glaucoma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sumatriptan succinate:

Sumatriptan succinate (9,731 reports)

Glaucoma treatments and more:

Glaucoma (61,928 reports)

Browse all side effects of Sumatriptan succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Glaucoma:

Glaucoma (1,233 drugs)

Browse all the conditions that are associated with Glaucoma:

Glaucoma (1,657 conditions)

Related publications that referenced our studies

Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .
Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .

How the study uses the data?

The study uses data from the FDA. It is based on sumatriptan succinate (the active ingredients of Sumatriptan succinate) and Sumatriptan succinate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.